Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250)

South Korea · Delayed Price · Currency is KRW

160,700

-6,500 (-3.89%)

Sep 11, 2026, 3:30 PM KST

Sam Chun Dang Pharm. Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	259,900	231,805	210,924	192,669	177,335	167,275
Revenue Growth	20.83%	9.90%	9.47%	8.65%	6.01%	0.25%
Gross Profit	122,727	109,091	99,285	96,605	89,630	82,835
Operating Income	17,705	8,325	2,563	9,560	12,569	-15,289
Net Income	17,782	5,262	-10,916	-10,383	5,838	-16,555
Earnings Per Share	762.42	226.24	-474.00	-463.03	264.52	-750.19
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	102,532	129,058	141,917	92,744	86,248	102,025
Total Debt	51,990	69,831	49,941	53,625	76,590	51,541
Net Cash (Debt)	50,542	59,227	91,975	39,119	9,658	50,484
Net Cash Growth	-6.64%	-35.61%	135.12%	305.04%	-80.87%	-32.59%
Net Cash Per Share	2167.03	2546.56	3993.76	1718.95	437.65	2287.64

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	26,082	9,793	21,771	23,428	13,279	-7,707
Capital Expenditures	-56,663	-46,146	-17,022	-6,766	-16,531	-14,882
Free Cash Flow	-30,581	-36,353	4,748	16,662	-3,252	-22,589
Free Cash Flow Growth	-	-	-71.50%	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	47.22%	47.06%	47.07%	50.14%	50.54%	49.52%
Operating Margin	6.81%	3.59%	1.21%	4.96%	7.09%	-9.14%
Pretax Margin	11.42%	5.40%	5.23%	-2.36%	5.03%	-11.69%
Profit Margin	6.84%	2.27%	-5.17%	-5.39%	3.29%	-9.90%
FCF Margin	-11.77%	-15.68%	2.25%	8.65%	-1.83%	-13.50%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	210.78	1027.68	-	-	165.58	-
Forward PE	-	111.99	111.99	111.99	111.99	111.99
P/FCF Ratio	-	-	727.36	105.58	-	-
PS Ratio	14.47	23.33	16.37	9.13	5.45	5.72